共 50 条
- [1] Phase II Trial of Weekly Nanoparticle Albumin-Bound Paclitaxel With Carboplatin and Trastuzumab as First-line Therapy for Women With HER2-Overexpressing Metastatic Breast CancerCLINICAL BREAST CANCER, 2010, 10 (04) : 281 - 287Conlin, Alison K.Seidman, Andrew D.Bach, AriadneLake, DianaDickler, MauraD'Andrea, GabriellaTraina, TiffanyDanso, MichaelBrufsky, Adam M.Saleh, MansoorClawson, AliciaHudis, Clifford A.
- [2] Paclitaxel, carboplatin, and trastuzumab in HER2-positive metastatic breast cancerCurrent Oncology Reports, 2005, 7 (1) : 9 - 11Andrew D. SeidmanLarry Norton
- [3] A phase II trial of neoadjuvant epirubicin/cyclophosphamide followed by weekly nanoparticle albumin-bound paclitaxel with trastuzumab for HER2-positive breast cancerCANCER RESEARCH, 2017, 77Kodera, A.Hirano, A.Inoue, H.Ogura, K.Hattori, A.Sakaguchi, S.Yukawa, H.Matsuoka, A.Tanaka, N.Kamimura, M.Jibiki, N.Fujibayasi, M.Naritaka, Y.Shimizu, T.
- [4] A Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel With or Without Trastuzumab in Metastatic Breast CancerCLINICAL BREAST CANCER, 2011, 11 (02) : 121 - 128Mirtsching, BarryCosgriff, ThomasHarker, GraydonKeaton, MarkChidiac, TarekMin, Myo
- [5] A phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancerCLINICAL BREAST CANCER, 2008, 8 (03) : 264 - 268Lucas Bayo-Calero, JuanMayordomo, Jose I.Salnchez-Rovira, PedroPerez-Carrion, RamonIllaramendi, Jose J.Garcia-bueno, Jose M.Gonzalez-Flores, EncarnacionCrespo, CarmenRamos-Vazquez, ManuelGarcia-Palomo, AndresRuiz-Borrego, Manuelde la Haba, JuanGomez-Bernal, AmaliaYubero-Esteban, Alfonso
- [6] Phase II study of neoadjuvant bevacizumab and trastuzumab administered with albumin-bound paclitaxel (nab paclitaxel) and carboplatin in HER2+locally advanced breast cancerJOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Raefsky, E.Castillo, R.Lahiry, A.Thompson, D. S.Hanson, S.Meng, C.Knauer, D.Trieu, V.Desai, N.Yardley, D. A.
- [7] Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)Datko, Farrah MikhailD'Andrea, GabriellaDickler, Maura N.Theodoulou, MariaGoldfarb, Shari BethLake, DianaFornier, Monica NancyModi, ShanuSklarin, Nancy T.Comen, Elizabeth AnneFasano, JulieGajria, DevikaDrullinsky, PamelaMurphy, Conleth G.Syldor, AngemaelPatil, SujataLiu, JenniferChandarlapaty, SaratHudis, CliffordDang, Chau T.
- [8] Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC).JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)Datko, Farrah MikhailD'Andrea, GabriellaDickler, Maura N.Goldfarb, Shari BethTheodoulou, MariaLake, DianaFornier, Monica NancyModi, ShanuFasano, JulieComen, Elizabeth AnneGajria, DevikaMoynahan, Mary EllenTraina, Tiffany A.Chen, MelanieHamilton, NicolaPatil, SujataChandarlapaty, SaratHudis, CliffordDang, Chau T.
- [9] Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients (pts) with HER2-positive metastatic breast cancer (MBC)JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Peacock, N. W.Infante, J. R.Yardley, D. A.Burris, H. A., IIIGreco, F. A.Farley, C.Webb, C.Spigel, D. R.Hainsworth, J. D.
- [10] A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancerBREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (02) : 471 - 475Yardley, DeniseBurris, Howard, IIIPeacock, NancyRaefsky, EricMelnik, MarianneInhorn, RogerShipley, DiannaHainsworth, John